Trial intelligence / Profile preview

Adjuvants added to ropivacaine for intravenous regional anesthesia in distal radius surgery

IRCT20141209020258N113Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Mar 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of dexmedetomidine, ketamine, neostigmine, magnesium sulfate and ropivacaine in distal forearm fracture and Forearm injuries (5 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: blood pressure, heart rate and 5 more. Started Mar 2019; status: completed.

02

Drugs

dexmedetomidineketamineneostigminemagnesium sulfateropivacaine
03

Conditions

distal forearm fractureForearm injuries

Beyond the preview

Go deeper on IRCT20141209020258N113.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141209020258N113.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call